AVITA Medical (ASX:AVH) EV-to-EBIT : -4.24 (As of May. 17, 2024)

View and export this data going back to 1993. Start your Free Trial

What is AVITA Medical EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, AVITA Medical's Enterprise Value is A$271.83 Mil. AVITA Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was A$-64.17 Mil. Therefore, AVITA Medical's EV-to-EBIT for today is -4.24.

The historical rank and industry rank for AVITA Medical's EV-to-EBIT or its related term are showing as below:

ASX:AVH' s EV-to-EBIT Range Over the Past 10 Years
Min: -255.39 Med: -10.17 Max: -1.02
Current: -4.9

During the past 13 years, the highest EV-to-EBIT of AVITA Medical was -1.02. The lowest was -255.39. And the median was -10.17.

ASX:AVH's EV-to-EBIT is ranked worse than
100% of 460 companies
in the Medical Devices & Instruments industry
Industry Median: 20.385 vs ASX:AVH: -4.90

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. AVITA Medical's Enterprise Value for the quarter that ended in Mar. 2024 was A$602.52 Mil. AVITA Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was A$-64.17 Mil. AVITA Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -10.65%.

AVITA Medical EV-to-EBIT Historical Data

The historical data trend for AVITA Medical's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AVITA Medical EV-to-EBIT Chart

AVITA Medical Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

-114.13

-13.90

-15.12

-3.30

-8.95

AVITA Medical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															-10.72	-12.10	-9.41	-8.95	-9.23

Competitive Comparison of AVITA Medical's EV-to-EBIT

For the Medical Devices subindustry, AVITA Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AVITA Medical's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AVITA Medical's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where AVITA Medical's EV-to-EBIT falls into.

AVITA Medical EV-to-EBIT Calculation

AVITA Medical's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	271.830	/	-64.166
	=	-4.24

AVITA Medical's current Enterprise Value is A$271.83 Mil.
AVITA Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was A$-64.17 Mil.

AVITA Medical (ASX:AVH) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

AVITA Medical's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	-64.166	/	602.52075
	=	-10.65 %

AVITA Medical's Enterprise Value for the quarter that ended in Mar. 2024 was A$602.52 Mil.
AVITA Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was A$-64.17 Mil.

AVITA Medical EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of AVITA Medical's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

AVITA Medical (ASX:AVH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AVITA Medical Inc (ASX:AVH) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

RCEL:USA AVHHL:USA 51KB:Germany

Address

28159 Avenue Stanford, Suite 220, Valencia, Los Angeles, CA, USA, 91355

Website

https://www.avitamedical.com

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the U.S.

AVITA Medical (ASX:AVH) Headlines

No Headlines